Date and Time: January 8, 2021 Time: 7:00 am – 8:30 am
Hosted by Wright Center, VCU Institute for Engineering and Medicine, Office of the Vice President for Research Innovation
Location: Virtually via Zoom
Continuing Education Credit: VCU Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. VCU Health also designates this activity for a maximum of 1 ANCC contact hours. Physicians and nurses should claim only the credit commensurate with the extent of their participation in the activity.
Course Description: This 3rd course in our series, attendees will understand the importance of securing intellectual property (IP) rights to support the translation of medical devices to the market. Session topics will explore how intellectual property rights support the commercialization process, the types of intellectual property most commonly encountered in university environments, best practices for disclosing your invention to a technology transfer office, how technology transfer offices evaluate and manage inventions, the requirements of and process for securing IP rights, and generating value from IP.
|7:00 a.m.||Welcome Address||L. Franklin Bost, MBA|
|7:05 a.m.||Review of Process||L. Franklin Bost, MBA|
|7:10 a.m.||Speaker||Michael Mancini, Ph.D.|
|8:00 a.m.||Q&A||L. Franklin Bost, MBA|
|8:20 a.m.||Closing Statements||L. Franklin Bost, MBA|
Michael Mancini, Ph.D., is the business development manager for Innovation Gateway, the full-service technology transfer office serving VCU. In this role, Dr. Mancini manages a portfolio of high-value medical technologies, primarily platform technologies, that require deep scientific and engineering knowledge and comprehensive business development experience to reach market. Prior to joining VCU, Dr. Mancini was a co-founder and the head of research and development for Spectropath, Inc. (Atlanta, GA), a medical device company spun out of Georgia Tech and Emory University, formed to commercialize an image-guided cancer surgery platform of which he is a co-inventor. Dr. Mancini received his B.S. in biomedical engineering (with distinction) from the University of Rochester, and completed his Ph.D. in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University under the supervision of Shuming Nie. The focus of his doctoral research was on optical instrumentation and nanomaterials, including considerations of toxicology, for biomedical imaging. He is an author of several well-cited scientific publications and a named inventor on two issued U.S. patents.